Literature DB >> 25138782

Governance practices and performance in US academic medical centers.

Marilyn Szekendi1, Lawrence Prybil2, Daniel L Cohen3, Beth Godsey4, David W Fardo2, Julie Cerese4.   

Abstract

Recognition of the complex nature of modern health care delivery has led to interest in investigating the ways in which various factors, including governance structures and practices, influence health care quality. In this study, the chief executive officers (CEOs) of US academic medical centers were surveyed to elicit their perceptions of board structures, activities, and attitudes reflecting 6 widely identified governance best practices; the relationship between use of these practices and organizational performance, based on the University HealthSystem Consortium's Quality & Accountability rankings, was assessed. High-performing hospitals showed greater use of all 6 practices, but the strongest evidence supported a focus on board member education and development, the rigorous use of performance measures to guide quality improvement, and systematic board self-assessment processes. All hospitals, even those with the highest quality ratings, had major gaps in their use of best practices for CEO and board assessments. These findings can serve as the basis for developing sound board improvement plans.
© The Author(s) 2014.

Keywords:  governance best practices; health care governance; patient safety; quality performance

Mesh:

Year:  2014        PMID: 25138782     DOI: 10.1177/1062860614547260

Source DB:  PubMed          Journal:  Am J Med Qual        ISSN: 1062-8606            Impact factor:   1.852


  2 in total

1.  The use of patient feedback by hospital boards of directors: a qualitative study of two NHS hospitals in England.

Authors:  Robert Lee; Juan I Baeza; Naomi J Fulop
Journal:  BMJ Qual Saf       Date:  2017-07-28       Impact factor: 7.035

2.  Understanding corporate governance of healthcare quality: a comparative case study of eight Australian public hospitals.

Authors:  Alison Brown
Journal:  BMC Health Serv Res       Date:  2019-10-21       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.